3D brain cancer platform for personalized medicine
Company 2019
MicroMatrices Associates Ltd, Dundee, United Kingdom
A high throughput histology platform was applied for testing drugs against tumors in a novel 3D heterotypic glioblastoma brain sphere model consisting of glioblastoma tumor cells, iPSC-derived neurons, glial cells and astrocytes grown in a spheroid. This platform provides a novel approach for screening new anti-glioblastoma agents and evaluating different treatment options for a given patient.
A human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
Simon Plummer
Added on: 05-25-2020
[1] https://www.nature.com/articles/s41598-018-38130-0